HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Skaane, P. Articles by Skjennald, A. Search for Related Content PubMed PubMed Citation Articles by Skaane, P. Articles by Skjennald, A.

Screen-Film Mammography versus Full-Field Digital Mammography with Soft-Copy Reading: Randomized Trial in a Population-based Screening Program—The Oslo II Study¹

¹ From the Department of Radiology, Breast Imaging Center, Ullevaal University Hospital, Kirkeveien 166, N-0407 Oslo, Norway. From the 2002 RSNA scientific assembly. Received October 7, 2003; revision requested November 3; revision received December 7; accepted January 2, 2004. Address correspondence to P.S. (e-mail: per.skaane@ulleval.no).

View larger version (48K): [in a new window]   Figure 1. Flowchart shows the number of women invited to participate in the Oslo II study and the attendance according to age group, as well as the number of women excluded from further analysis because the modality of their examination differed from that assigned. Overall, 72% of the women examined underwent SFM, and 28% underwent FFDM.

View larger version (30K): [in a new window]   Figure 2. Flowchart shows the Oslo II study design for the comparison of SFM with FFDM with soft-copy reading. Prior mammograms, if available, were offered for comparison at both the SFM and the FFDM consensus meetings but not at the initial interpretation sessions.

View larger version (35K): [in a new window]   Figure 3. Flowchart shows the numbers of detected cancers and cancers excluded from analysis in the Oslo II study.

View larger version (23K): [in a new window]   Figure 4. Flowchart shows cancer detection rates at SFM and FFDM according to age group (45-49 or 50-69 years) in the Oslo II study.